Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alain Azan currently holds 20,517 shares of Anthera Pharmaceuticals Inc (ANTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alain Azan has been a net buyer of ANTH stock. They have purchased $2.6M and sold $155.8K worth of shares.
Alain Azan's most recent insider trade was on Feb 5, 2013, when they sold 11,226 shares at $0.00 per share.
Alain Azan serves as Executive at Anthera Pharmaceuticals Inc (ANTH). They have executed 36 insider transactions totaling $2.7M over their tenure at the company.
Alain Azan holds the position of Executive at Anthera Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Alain Azan has shown a buying trading pattern, with $2.6M in total purchases and $155.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Alain Azan was on May 15, 2006, when they purchased $2.5M worth of NOVC shares. This transaction involved 391,030 shares at $6.50 per share.
Alain Azan currently owns 20,517 shares of Anthera Pharmaceuticals Inc (ANTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alain Azan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alain Azan has 36 Form 4 filings on record as an insider at Anthera Pharmaceuticals Inc.
Set alerts for Alain Azan and 40,000+ other insiders.